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with dyspnea and wheezing. Stool examination 
was performed to further evaluate eosinophilia, 
which remained stable. Microscopic studies of 
the stool samples revealed the larvae of Strongy‑
loides stercoralis (S. stercoralis) (FIGurE 1B). More‑
over, expectorated sputum samples contained 
the rhabditiform larvae of S. stercoralis (FIGurE 1C). 
The test for human T ‑cell lymphotropic virus type 
1 and 2 quantitative antibodies yielded negative 
results. The results of serological evaluation for 
other parasitic infections (toxocarosis and echi‑
nococcosis) were negative. The patient’s history 
was re ‑evaluated and revealed past employment 
at water well construction.
A 75 ‑year ‑old man diagnosed with follicular lym‑
phoma 3 years earlier was admitted to the De‑
partment of Rheumatology and Immunology 
due to expiratory wheezing and worsening dys‑
pnea during the last 3 months. Also, the patient 
had a 2 ‑year history of paroxysmal cough and 
pruritus. He also complained of periodic ab‑
dominal pain and borborygmi occurring during 
the last 3 years. Empiric clarithromycin thera‑
py for suspected bronchitis, administered pri‑
or to admission, did not improve respiratory 
symptoms. Physical examination revealed dif‑
fuse expiratory wheezing and multiple erythem‑
atous linear streaks on the patient’s trunk and 
extremities (FIGurE 1A). The physical examina‑
tion was otherwise unremarkable. Initial work‑
up revealed eosinophilia (1172 cells/ul; refer‑
ence range, 40–450 cells/ul) and normal levels 
of vitamin B12, tryptase as well as immunoglob‑
ulins G and E. The patient tested negative for 
FIP1L1 ‑PDGFRA, JAK2, and ETV6 ‑PDGFRB mu‑
tations. His medical records showed that eosin‑
ophilia gradually increased since immunochemo‑
therapy for follicular lymphoma had been start‑
ed 3 years earlier (8 cycles of R ‑CVP therapy, ie, 
rituximab, cyclophosphamide, vincristine, and 
prednisolone, followed by 10 cycles of rituximab 
every 2 months, with the latest cycle adminis‑
tered a month prior to the described presenta‑
tion). Chest X ‑ray and computed tomography did 
not demonstrate interstitial infiltrates. Abdom‑
inal ultrasonography and echocardiography re‑
vealed no significant abnormalities. The patient 
was unable to undergo spirometry due to dyspnea 
and cough. Following the initial suspicion of eo‑
sinophilic bronchitis, intravenous methylpred‑
nisolone (80 mg daily for 6 days, subsequent‑
ly tapered) combined with inhaled budesonide 
(2000 μg twice daily) and inhaled bronchodilators 
were started. The patient continued to deteriorate 
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FIGurE 1 A – multiple erythematous linear streaks on 
the patient’s trunk
A
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Steroids were discontinued and albendazole 
(400 mg twice daily) was administered until stool 
examination was negative for S. stercoralis for 
2 consecutive weeks. The treatment was contin‑
ued for 28 days and resulted in the improvement 
of respiratory signs and symptoms and reduction 
of eosinophil count.
Strongyloidiasis is an infestation caused by 
S. stercoralis.1 While prevalent in the tropical and 
subtropical regions of the world,2 data on S. ster‑
coralis occurrence in Poland are scarce.3 Transmis‑
sion occurs through skin inoculation with larvae 
residing in soil or via the fecal–oral route through 
ingestion of the parasite’s eggs.3,4 The affected pa‑
tients present with nausea, diarrhea, weight loss, 
abdominal pain, as well as pulmonary and skin 
symptoms manifesting high ‑burden disease.2,4 In 
some cases (eg, corticosteroid treatment, human 
T ‑cell lymphotropic virus type 1 infection, hypo‑
gammaglobulinemia, and hematologic malignan‑
cies), patients may develop hyperinfection syn‑
drome or disseminated disease eventually lead‑
ing to shock and alveolar hemorrhage.2,4,5 Treat‑
ment options include either albendazole or iver‑
mectin use, both drugs with proven efficacy.1-3 
Eosinophilia, especially in the context of immu‑
nosuppression and gastrointestinal, dermato‑
logical, or respiratory symptoms should prompt 
evaluation for Strongyloides infestation and em‑
piric antiparasitic therapy prior to administra‑
tion of glucocorticoids to prevent fatal dissem‑
ination of the disease.
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FIGurE 1 B, C – a rhabditiform larva of Strongyloides stercoralis in the iodine -stained wet mount of the stool 
(B, magnification × 100) and in the unstained wet mount of the expectorated sputum (C, magnification × 100)
